Abstract
While organ transplantation has emerged as a successful treatment option for certain human diseases, failure to induce life-long graft tolerance remains the most significant obstacle to achieving optimal post-op outcomes. To better cope with this challenge, it is particularly important to understand and distinguish between the different mechanisms that induce graft rejection. After transplantation, host immune responses can be triggered by both stranger and danger signals. Genetic differences between individuals contribute to the identification of foreign entities by recipient immune cells. The recovery and preservation of organs lead to the cell stress or death, inducing inflammation and further aggravating graft damage. Herein, I aim to summarize the modern understanding of transplant immunology and compare the current medical scheme with innovative strategies. This review focuses on recent progresses in stem cell transplant and compiles technological breakthroughs to improve autologous iPSC therapeutics.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
